Target intelligence / Profile preview

Aluminum cation (Al³⁺)

Target
Al³⁺
Molecular classification
Other
01

Overview

The **aluminum cation** (Al³⁺) is the trivalent, positively charged ion formed when a neutral aluminum atom loses its three outermost electrons, resulting in the electron configuration of [Ne] 1s² 2s² 2p⁶, which is stable and confers high Lewis acidity[1][3]. In aqueous environments, it most commonly exists as the hydrated complex [Al(H₂O)₆]³⁺[1][4]. Aluminum cations play a role in the environment and biological systems primarily through chemical reactivity, such as forming stable complexes with ligands like citrate and proteins (e.g., transferrin)[4][8]. There is evidence that aluminum cations may be involved in the compaction of biomolecules, specifically chromatin, and may thus have an indirect role in epigenetics[2]. However, they are not classified as *therapeutic targets*—they are not receptors, enzymes, ion channels, or transporters as typically recognized in pharmacological research and drug development. Instead, aluminum cations are generally considered environmental or toxic metal ions, with no direct physiological targets or endogenous biological receptors[2][4]. Their accumulation and neurotoxicity in humans have raised concerns regarding possible contributions to neurodegenerative disorders such as Alzheimer's disease[7]. Summary of correctness: The entry "Aluminum cation" is **not** a therapeutic target in the usual biomedical sense and is therefore flagged as incorrect for standard pharmacological target lists. It is a metal ion, not a biologically regulated protein or molecular target amenable to conventional drug interaction. While it binds biological molecules and may be involved in pathological or environmental processes, it does not meet the criteria of a receptor, enzyme, transporter, etc.

Other names
Aluminium ionAl(III)Al^3+Al(3+)Aluminium(3+)
02

Biological functions

Biomolecular compactionChromatin condensationOther
03

Disease associations

Other
04

Safety considerations

NeurotoxicityAccumulation in tissuesPotential role in Alzheimer's diseasePotential for DNA/chromatin compaction leading to epigenetic changes

Beyond the preview

Go deeper on Aluminum cation (Al³⁺).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aluminum cation (Al³⁺).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call